Home / Solifenacin / Belgium
BE ATC G04BD08 · updated 2 Nov 2026
Solifenacin shortage in Belgium
Is there a Solifenacin shortage in Belgium?
Yes. As of 2 Nov 2026, 5 Solifenacin products are reported short in Belgium, the first since 14 Mar 2025. The company estimate for the return is 15 Dec 2026 (latest 8 Feb 2027). Main reason: manufacturing problem.
Also short in Canada, Italy, Spain, Czechia, Australia. All countries.
Affected products in Belgium
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| BE | Solifenacin Krka 10 mg film-coat. tabl. 250 | KRKA d.d. Novo mesto | 14 Mar 2025 | 25 Jan 2027 | Manufacturing problem Delay in production |
| BE | Solifenacin Krka 5 mg film-coat. tabl. 250 | KRKA d.d. Novo mesto | 14 Mar 2025 | 25 Jan 2027 | Manufacturing problem Delay in production |
| BE | Solifenacine Viatris 10 mg film-coat. tabl. 90 | Viatris GX | 11 Sep 2026 | 15 Dec 2026 | Other Other reason |
| BE | Solifenacine Teva 10 mg film-coat. tabl. 30 | Teva | 29 Sep 2026 | 8 Feb 2027 | Manufacturing problem Delay in production |
| BE | Solifenacine Viatris 5 mg film-coat. tabl. 90 | Viatris GX | 1 Oct 2026 | 15 Dec 2026 | Other Other reason |
Source
FAMHP (Federal Agency for Medicines and Health Products), PharmaStatus / SAMv2. Official list. All authorised packs with a declared temporary unavailability.